US Patent Issued to Suzhou Zelgen Biopharmaceuticals, Shanghai Zelgen Pharma.Tech on March 24 for "Anti-human CD47 antibody and antigen-binding fragment thereof, and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,935, issued on March 24, was assigned to Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Suzhou, China) and Shanghai Zelgen Pharma.Tech Co. Ltd. (Shanghai).

"Anti-human CD47 antibody and antigen-binding fragment thereof, and preparation method therefor and use thereof" was invented by Liyun Gu (Shanghai), Yong Zhao (Shanghai), Shifu Mo (Shanghai), Wei Xu (Shanghai), Jie Yang (Shanghai), Dong Ding (Shanghai) and Zhichao Wang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in the present invention are an anti-human CD47 antibody or an antigen-binding fragment thereof, and a preparation method therefor and the use thereof. Also provided i...